Best Clean Energy Stocks To Buy Right Now

Exelon (NYSE: EXC  ) reported earnings (link saves as PDF) today, beating analyst estimates on both top-line and bottom-line numbers.

First-quarter 2013 sales clocked in at $6.89 billion, 11% above analyst expectations of $6.2 billion. This quarter's results are 9.7% higher than Q4 2012, and up 47% from 2012's first quarter (before the company's Constellation merger).

On the bottom line, adjusted EPS fell 17.6% year over year to $0.70, but still managed to beat analyst estimates by $0.02.

CEO Christopher Crane pointed to solid nuclear fleet capacity, improving power prices, and increasingly large synergies from last year's merger�as reasons for Exelon's success.

Looking ahead, the utility reaffirmed its Q2 $0.50 to $0.60 guidance, as well as its 2013 $2.35 to $2.65 EPS, despite lower expected margins for its Constellation segment.

As the nation moves increasingly toward clean energy, Exelon is perfectly positioned to capitalize on having the largest nuclear fleet in North America. This strength, combined with an increased focus on balance sheet health and its recent merger with Constellation, places Exelon and its resized dividend on a short list of the top utilities. To determine if Exelon is a good long-term fit for your portfolio, you're invited to check out The Motley Fool's premium research report on the company. Simply click here now for instant access.

Hot Communications Equipment Stocks To Own For 2015: China Ming Yang Wind Power Group Ltd (MY)

China Ming Yang Wind Power Group Limited incorporated on February 26, 2009, is a wind turbine manufacturer in China, focusing on designing, manufacturing, selling and servicing megawatt-class wind turbines. The Company�� products consist of basic models of wind turbines, each with a rated power capacity of 1.5 megawatt (MW); wind turbines with a rated power capacity of 2.0MW, and 2.5/3.0MW SCD wind turbines. Each product type may be installed with one of three rotor blade models depending on the location and wind conditions. As of December 31, 2012, the Company had entered into sales contracts with 37 end customers to deliver 3,730 units of its wind turbines.

It cooperates with aerodyn Energiesysteme to develop its 1.5 megawatt wind turbines and share intellectual property rights. It also has obtained licenses from aerodyn Asia Co., Ltd. (aerodyn Asia) to manufacture and distribute wind turbines utilizing its super-compact drive (SCD) technology, with a rated power capacity of 6.0MW.

The Company�� customers are the Chinese state-owned power producers which include Huaneng, China Datang, Huadian, China Guodian Corporation, and China Power Investment Corporation (CPIC) or their alternative energy subsidiaries, such as China Longyuan Power Group Corporation Limited (Longyuan), a subsidiary of Guodian, and China Datang Corporation Renewable Power Co., Limited (Datang Renewable), a subsidiary of China Datang. It also sells wind turbines to regional alternative energy investment companies, regional power producers and wind farm operators in the private sector. Its facilities are located in Zhongshan, Tianjin, Jilin, Rudong, Dali and Inner Mongolia in China.

The Company produces megawatt-class, grid-connected, horizontal-axis wind turbines, equipped with a double-fed constant frequency induction generator, which is a design of the generator that enables the generator to produce electric current of a constant frequency as the shaft rotates at varying speeds causing! the generator rotor to rotate at varying speed. It offers 1.5 megawatt turbines specially designed and developed for the wind and weather conditions and power grids in China. Its 1.5 megawatt wind turbines are equipped with rotor blades with a post-installation diameter of 77.1 meters, 82.6 meters or 89.0 meters.

The Company has license rights under a license agreement from aerodyn Asia to manufacture and distribute 2.5/3.0MW SCD wind turbines and 6.0MW SCD wind turbines in China. The Company is focused on developing 3.8MW wind turbine model for larger multi-megawatt wind turbines.

The Company competes with Sinovel, Goldwind, Dongfang Electric, United Power, Vestas, Gamesa Corporacion Tecnologica S.A. and GE Energy.

Advisors' Opinion:

• [By Garrett Cook]

  In trading on Tuesday, industrials shares were relative leaders, up on the day by about 0.26 percent. Top gainers in the sector included Perceptron (NASDAQ: PRCP), up 10.9 percent, China Ming Yang Wind Power Group (NYSE: MY), up 4.8 percent.

• [By John Udovich]

  Small cap wind stock Broadwind Energy Inc (NASDAQ: BWEN) is up 203.7% since the start of the year, but investors might want to contain their excitement when they look closer at the�stock and�consider its�long term performance along with the performance of other wind investments like First Trust Global Wind Energy ETF (NYSEARCA: FAN) and wind energy stocks Vestas Wind Systems (OTCMKTS: VWDRY) and China Ming Yang Wind Power Group Ltd (NYSE: MY) to see whether BWEN is just blowing more hot air.

Best Clean Energy Stocks To Buy Right Now: Jazz Pharmaceuticals Inc.(JAZZ)

Jazz Pharmaceuticals, Inc., a specialty pharmaceutical company, engages in the identification, development, and commercialization of pharmaceutical products to meet unmet medical needs. The company markets Xyrem, a sodium oxybate oral solution for the treatment of both cataplexy and excessive daytime sleepiness in patients with narcolepsy; and Luvox CR extended-release capsules for the treatment of obsessive compulsive disorder. Its product candidates under clinical development include JZP-6, a Phase III pivotal clinical trials completed product for the treatment of fibromyalgia; and JZP-8, an intranasal formulation of clonazepam, which has completed Phase II clinical trial for the treatment of acute repetitive seizures in epilepsy and solid oral dosage forms of sodium oxybate. The company sells its products through specialty sales force targeting sleep specialists, psychiatrists, neurologists, and pulmonologists. Jazz Pharmaceuticals, Inc. was founded in 2003 and is headq uartered in Palo Alto, California.

Advisors' Opinion:

• [By Michael Robinson]

  Jazz Pharmaceuticals PLC (JAZZ) has a strong expertise in treating narcolepsy, chronic pain, blood disease, cancer, and some psychiatric disorders.

• [By Sean Williams]

  What: Shares of biopharmaceutical company Jazz Pharmaceuticals (NASDAQ: JAZZ  ) dipped as much as 10% after the company reported its first-quarter results and following regulatory comments with regard to generic competition to its lead drug.

Best Clean Energy Stocks To Buy Right Now: Weir Group PLC (WEIR)

The Weir Group PLC is engaged in engineering businesses. It operates in three segments: Minerals, Oil and Gas, and Power and Industrial. The Minerals segment provides slurry handling equipment and associated aftermarket support for abrasive high wear applications used in the mining and oil sands markets. The Oil & Gas segment provides products and service solutions to upstream, production, transportation, refining and related industries. The Power & Industrial segment designs and manufactures valves, pumps and turbines as well as providing specialist support services to the global power generation, industrial and oil and gas sectors. The Company�� subsidiaries include American Hydro Corporation, EnviroTech Pumpsystems Inc, Gema Industrigummi AB, Linatex Rubber Products Sdn Bhd and Mesa Manufacturing Inc. Advisors' Opinion:

• [By Inyoung Hwang]

  Weir Group Plc (WEIR) added 1.6 percent to 2,239 pence, the highest price in almost two months. The U.K.�� largest supplier of pressure pumps was raised to buy from hold at Berenberg Bank.

Best Clean Energy Stocks To Buy Right Now: Compania Mina Buenaventura S.A. (BVN)

Compania de Minas Buenaventura S.A.A., a precious metals company, engages in the exploration, mining, processing, and development of gold, silver, and other metals in Peru. It also explores for zinc, lead, and copper. The company operates the Orcopampa mine located in the province of Castilla in the department of Arequipa; the Uchucchacua mine located in the province of Oyon in the department of Lima; the La Zanja mine located in the district of Pulan in the province of Santa Cruz; the Antapite mine located in the province of Huaytara in the department of Huancavelica; the Julcani mine located in the province of Angaraes in the department of Huancavelica; and the Recuperada mine located in the province of Huancavelica in the department of Huancavelica. It also holds controlling interests in the Colquijirca and Marcapunta Norte mines located east of the city of Lima; and the Shila-Paula mines located in the province of Castilla in the department of Arequipa. In addition, th e company owns interests in various other mining companies. Further, it offers electric power transmission services; and geological, engineering, design, and construction consulting services to the mining sector. Compania de Minas Buenaventura S.A.A. was founded in 1953 and is headquartered in Lima, Peru.

Advisors' Opinion:

• [By Ben Levisohn]

  Yesterday, for instance, the Wall Street Journal reported that local opposition to the Minas Conga project in Peru, a joint venture between Newmont Mining and Compania de Minas Buenaventura (BVN), could be dissipating. The Wall Street Journal reports:

Best Clean Energy Stocks To Buy Right Now: Continental AG (CON)

Continental AG is a Germany-based holding company and automotive industry supplier. It operates two business groups: Automotive Group and Rubber Group. The Automotive Group is divided into Chassis & Safety division, Powertrain division and Interior division. The Chassis & Safety division focuses on the areas of networked driving safety, brakes, driver assistance, chassis, active and passive safety and sensor technology for the avoidance of accidents and injury. The Powertrain division specializes in the powertrain solutions. The Interior division focuses on information, communication and networking solutions. The Rubber Group is divided into Tire division and ContiTech divisions. The Tire division comprises Passenger and Light Truck Tires, including tires for motorcycles. The ContiTech division develops and manufactures functional parts, components and systems for the automotive industry. In February 2014, it acquired Veyance Technologies Inc. Advisors' Opinion:

• [By Ruth David]

  Schaeffler AG, the largest investor in Hanover, Germany-based Continental AG (CON), raised 950 million euros on Sept. 17 by selling a 4 percent stake in Europe�� second-largest car-parts maker to reduce debt. Telegraaf Media Groep NV, the publisher of the largest Dutch newspaper, exited its holding in German broadcaster ProSiebenSat.1 Media AG on Sept. 6, making proceeds of about 391 million euros.

• [By Jonathan Morgan]

  Volkswagen, Europe�� biggest automaker, gained 3.7 percent to 168.40 euros. Daimler AG, the third-biggest luxury-vehicle maker, rose 3.9 percent to 49 euros, its highest price since August 2011. Continental AG (CON), Europe�� second-largest auto-parts maker, added 3 percent to 100.30 euros. A measure of carmakers posted the best performance of the 19 industry groups on the Stoxx Europe 600 Index.

Best Clean Energy Stocks To Buy Right Now: Omeros Corporation(OMER)

Omeros Corporation, a clinical-stage biopharmaceutical company, engages in discovering, developing, and commercializing products targeting inflammation, coagulopathies, and disorders of the central nervous system. Its product candidates are derived from its proprietary PharmacoSurgery platform that is designed to improve clinical outcomes of patients undergoing arthroscopic, ophthalmological, urological, and other surgical and medical procedures. The company?s lead PharmacoSurgery product candidates include OMS103HP, a Phase 3 clinical program evaluated for OMS103HP?s safety and ability to improve postoperative joint function and reduce pain following arthroscopic partial meniscectomy surgery, and arthroscopic anterior cruciate ligament; OMS302, a Phase 2b clinical trial completed product candidate for use during ophthalmological procedures, including cataract and other lens replacement surgery; and OMS201, a Phase 1/Phase 2 clinical trial completed program for use durin g urological surgery. It also engages in developing proprietary compositions that comprise peroxisome proliferator-activated receptor gamma agonists for the treatment and prevention of addiction to substances of abuse. The company?s pipeline of preclinical product development programs includes Plasmin for Surgical and traumatic bleeding; PDE7 for addictions and compulsive disorders, and movement disorders; MASP-2 for macular degeneration, ischemia-reperfusion injury, transplant surgery, and radiation injury; and PDE10 for Schizophrenia. Omeros Corporation was founded in 1994 and is based in Seattle, Washington.

Advisors' Opinion:

• [By Paul Ausick]

  Stocks on the move: Boise Inc. (NYSE: BZ) is up 26% at $12.55 following the company�� acquisition by Packaging Corporation of America Inc. (NYSE: PKG) for $12.55 a share ($1.28 billion). Omeros Corp. (NASDAQ: OMER) is up 68.2% at $8.56 following an analyst upgrade. Northern Dynasty Minerals Ltd. (NYSEArca: NAK) is down 33.3% at $1.48 following an announcement from Anglo American plc that it was withdrawing from a massive copper mining project in Alaska.

• [By John Udovich]

  Last week had been a busy week for biotech IPOs and follow-on offerings plus news from small cap biotech stocks like Omeros Corporation (NASDAQ: OMER), Argos Therapeutics Inc (NASDAQ: ARGS), Revance Therapeutics Inc (NASDAQ: RVNC) and TNI BioTech (OTCMKTS: TNIB) that�� worth noting as a new trading week begins:�

• [By John Udovich]

  The biotech sector has been hot this year with�small cap biotech stocks�Fate Therapeutics Inc (NASDAQ: FATE),�Omeros Corporation(NASDAQ: OMER) and TNI BioTech (OTCMKTS: TNIB) being among those biotech stocks in the news this week. However, there has also been talk�and perhaps�some signs of a bubble in biotech that investors and traders alike need to consider. With that in mind, here is a recap of the latest news for biotech or small cap biotech stocks:

• [By John Udovich]

  Small cap orphan drug stocks Zalicus Inc (NASDAQ: ZLCS), Omeros Corporation (NASDAQ: OMER) and Viropharma Inc (NASDAQ: VPHM) have been active lately thanks to good news about their orphan drug treatments. In case you aren�� familiar with the term, orphan drug designation by the FDA is granted for drugs targeting conditions affecting 200,000 or fewer US patients annually that are expected to provide significant therapeutic advantage over existing treatments. The designation will also qualify companies for benefits across all stages of drug development, such as�accelerated approval processes, seven years of market exclusivity�after marketing approval, tax credits on�any US�clinical trials, grants and waiver of certain administrative fees.